(Total Views: 479)
Posted On: 06/05/2021 8:00:48 PM
Post# of 148949
Re: mountaineer #92985
Because the University doing the study has no idea what dosage timing they're aiming for.
https://reporter.nih.gov/project-details/10064937
Quote:
However, a once-quarterly at home formulation would dramatically increase patient adherence. To this end we will develop a novel formulation of long-acting Leronlimab that can be administered at home in a low volume able to provide coverage for three months.
https://reporter.nih.gov/project-details/10064937
(1)
(0)Scroll down for more posts ▼
